Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-30T16:05:04.925Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence of Bipolar Depression

Published online by Cambridge University Press:  07 November 2014

Robert M. Post
Get access Rights & Permissions [Opens in a new window]

Extract

Recent data indicate that bipolar illness is underdiagnosed and therefore undertreated in the community (Slide 1). A recent survey of >85,000 households in the United States found a 3.7% positive screen for prominent bipolar symptomatology. Using the Mood Disorder Questionnaire, which has good specificity and sensitivity in outpatient clinics, the study also found that the prevalence was higher, 9.3%, among patients 18–24 years of age. However, most disappointing was that only 20% of the positive screens were diagnosed as bipolar, and among those, most were not treated with mood stabilizers. In addition, 31% of patients had been diagnosed with unipolar depression. Several studies have shown that approximately 20% to 40% of presumptively unipolar patients actually have bipolar II or bipolar disorder not otherwise specified. Combined, the data show that bipolar disorder, bipolar depression in particular, is highly prevalent and often misdiagnosed or unrecognized.

Two recent studies found virtually the same data showing that depression is the predominant problem in naturalistically treated bipolar outpatients. Judd and colleagues found that depression was three times more prevalent than mania in bipolar patients. This is exactly what was found in the Stanley Foundation bipolar outpatient follow-up study, which rated the study's first 258 patients every day for 1 year (Slide 2). The study found that patients were ill almost 50% of the time; they were depressed 33% of the days in the year, and hypomanic or manic 10.8% of the days. This occurred despite aggressive treatment with a variety of agents, such as mood stabilizers, antidepressants, and benzodiazepines in 50% of the patients, and typical or atypical neuroleptics in almost 50% of the patients. Thus, even bipolar patients who are intensively treated in academic settings have a very substantial degree of morbidity, particularly depression.

Type
Research Article
Information
CNS Spectrums , Volume 8 , supplement S12: Treatment of Bipolar Depression , December 2003 , pp. 2 - 3
Copyright
Copyright © Cambridge University Press 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Hirschfeld, RM, Calabrese, JR, Weissman, MM, et al.Screening lor bipolar disorder in the community. J Clin Psychiatry. 2003;64:53–59.CrossRefGoogle Scholar
2.Akiskal, HS, Bourgeois, ML, Angst, J, et al.Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000;59(suppl 1):S5–S30.CrossRefGoogle ScholarPubMed
3.Angst, J, Gamma, A, Benazzi, F, et al.Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord. 2003;73:133–146.CrossRefGoogle Scholar
4.Judd, LL, Akiskal, HS, Schettler, PJ, et al.The long-term narural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59:530–537.CrossRefGoogle Scholar
5.Post, RM, Denicoff, KD, Leverich, GS, et al.Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH Life Chart Method. J Clin Psychiatry. 2003;64:680–690.CrossRefGoogle ScholarPubMed
6.Leverich, GS, Altshuler, LL, Frye, MA, et al.Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry. 2003;64:506–515.CrossRefGoogle ScholarPubMed
7.Post, RM, Leverich, GS, Nolen, WA, et al.A reevaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Bipolar Treatment Network. Bipolar Disord. 2003. In press.Google Scholar
8.Altshuler, L, Kiriakos, L, Calcagno, J, et al.The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry. 2001;62:612–616.CrossRefGoogle ScholarPubMed
9.Altshuler, L, Suppes, T, Black, D, et al.Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry. 2003;160:1252–1262.CrossRefGoogle ScholarPubMed
10.Coppen, A, Chaudhry, S, Swade, C. Folic acid enhances lithium prophylaxis. J Affective Disord. 1986;10:9–13.CrossRefGoogle ScholarPubMed
11.Coppen, A, Bailey, J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled trial. J Affect Disord. 2000;60:121–130.CrossRefGoogle Scholar
12.Stoll, AL, Severus, WE, Freeman, MP, et al.Omega-3 fatty acids m bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56:407–412.CrossRefGoogle Scholar
13.PE, Keck Jr, McElroy, SL, Freeman, MP, et al.Randomized, placebo-controlled trial of eicosapentanoic acid in bipolar depression. Bipolar Disord. 2003;5:58.Google Scholar
14.Marangell, LB, Martinez, JM, Zboyan, HA, et al.A double-blind, placebo-controlled srudy of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003;160:996–998.CrossRefGoogle Scholar